We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00351572
Recruitment Status : Completed
First Posted : July 13, 2006
Last Update Posted : April 18, 2011
Sponsor:
Information provided by:

Study Description
Brief Summary:
This study will determine whether a new diagnostic test called the Cell Search Assay can detect circulating colon cancer cells in patients who have had surgery for colon cancer and had visible cancer removed. Other parts of the study will look at whether the presence of the circulating tumor cells in blood predicts whether a patient will have their colon cancer return.

Condition or disease Intervention/treatment
Colon Cancer Procedure: Cell Search Assay

Study Design

Study Type : Observational
Estimated Enrollment : 30 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients
Study Start Date : July 2006
Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
primary care clinic and any other interested parties
Criteria

Inclusion Criteria:

  • stage II or III colon cancer

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00351572


Locations
Canada, Alberta
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2
Sponsors and Collaborators
Alberta Health Services
Investigators
Principal Investigator: Michael Sawyer, MD AHS Cancer Control Alberta
More Information

ClinicalTrials.gov Identifier: NCT00351572     History of Changes
Other Study ID Numbers: GI-5-0055
First Posted: July 13, 2006    Key Record Dates
Last Update Posted: April 18, 2011
Last Verified: April 2011

Keywords provided by AHS Cancer Control Alberta:
colon cancer

Additional relevant MeSH terms:
Colonic Neoplasms
Neoplastic Cells, Circulating
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Neoplasm Metastasis
Neoplastic Processes
Pathologic Processes